Morita Akane

Research field (1)： Pharmacology

Research theme for competitive and other funds (4)：

2021 - 2024 Establishment of a novel experimental model of retinal pericyte deletion for accelerating the development of therapeutic agents for diabetic retinopathy
2020 - 2023 病的網膜血管特異的な増殖・生存シグナル分子の可視化による抗血管新生薬の評価系構築
2018 - 2020 Molecular mechanisms for suppressing the migration of endothelial cells by excessive VEGF
2015 - 2018 網膜血管形成のプログラム破綻がもたらす血管パターン異常と網膜症リスクとの関連

Papers (31)：

Honoka Yamagishi, Nozomu Kirai, Akane Morita, Toshihide Kashihara, Tsutomu Nakahara. Role of monocarboxylate transporters in AMPK-mediated protection against excitotoxic injury in the rat retina. European journal of pharmacology. 2024. 176510-176510
Erika Kamiya, Akane Morita, Asami Mori, Kenji Sakamoto, Tsutomu Nakahara. The process of methylglyoxal-induced retinal capillary endothelial cell degeneration in rats. Microvascular research. 2023. 146. 104455-104455
Asami Mori, Yuna Ezawa, Daiki Asano, Toshiki Kanamori, Akane Morita, Toshihide Kashihara, Kenji Sakamoto, Tsutomu Nakahara. Resveratrol dilates arterioles and protects against N-methyl-d-aspartic acid-induced excitotoxicity in the rat retina. Neuroscience letters. 2023. 793. 136999-136999
柏原俊英, 森田祐生, 平島枝里, 森田茜, 中原努. ラットNMDA誘発網膜神経傷害モデルにおけるYAPの発現変化. 日本眼薬理学会プログラム・抄録集. 2022. 42回. 51-51
森田茜, 菅原志央吏, 入田孟大, 柏原俊英, 森麻美, 坂本謙司, 中原努. VEGF受容体阻害薬を用いた新生仔マウス新規網膜異常血管新生モデル. 眼薬理. 2022. 36. 1. 76-78

ｍore...

MISC (22)：

ｍore...

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page